| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.435 | 12.813 | 18.419 | 30.589 | 30.988 | 0 |
| Total Income - EUR | - | - | - | - | 3.435 | 12.813 | 18.419 | 30.589 | 36.391 | 0 |
| Total Expenses - EUR | - | - | - | - | 1.582 | 6.330 | 6.841 | 9.919 | 20.538 | 6.307 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.852 | 6.483 | 11.578 | 20.670 | 15.853 | -6.307 |
| Net Profit/Loss - EUR | - | - | - | - | 1.755 | 6.217 | 11.169 | 19.908 | 15.490 | -6.307 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 2 | 0 |
Check the financial reports for the company - U&Bdiagnostics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 4.345 | 3.332 | 2.218 | 12.658 | 8.419 |
| Current Assets | - | - | - | - | 2.885 | 4.494 | 16.711 | 18.591 | 13.531 | 11.481 |
| Inventories | - | - | - | - | 0 | 0 | 109 | 109 | 169 | 0 |
| Receivables | - | - | - | - | 712 | 769 | 1.623 | 12.515 | 0 | 0 |
| Cash | - | - | - | - | 2.172 | 3.726 | 14.980 | 5.966 | 13.362 | 11.481 |
| Shareholders Funds | - | - | - | - | 1.965 | 8.145 | 19.133 | 20.151 | 25.448 | 18.999 |
| Social Capital | - | - | - | - | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | 953 | 1.051 | 1.271 | 900 | 979 | 1.000 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - U&Bdiagnostics S.r.l.